Who we Are

We focus on the performance and growth of promising technologies in the life science sector

Who we are

We are a Swiss company focusing on the value development and commercialization of promising early-stage research projects from universities and other research institutions in the life sciences industry with the goal to offer solutions for high unmet medical need and better life quality. Our goal is to build a bridge from research and development to the healthcare markets.
We bring selected projects in the four areas of technology platforms, biotechnologies/therapies, medical technology (health technology), and artificial intelligence in the life science sector and digital health to the next stage of development.

Sustainability

Xlife Sciences and its project companies act in a responsible and sustainable way. We are able to reduce animal testing to a minimum through innovative technologies. In addition, we regularly engage in innovative healing trials for severe and partly incurable diseases. This has a great impact for treated patients. Sustainability has also high priority in the production. In the area of bioprinting and pharmaceuticals, project companies produce with low energy consumption and little by-products. We support sustainable business travel and are a sustainability sponsor of Carbon Connect.

our Team

Board of Directors, Management and Senior Advisors

Dr. Bernhard Scholz
Dr. Bernhard Scholz
President of the Board of Directors
David L. Deck
David L. Deck
Member of the Board of Directors
Mark S. Müller
Mark S. Müller
Member of the Board of Directors
Désirée Dosch
Désirée Dosch
Member of the Board of Directors
Simon Schöni
Simon Schöni
Member of the Board of Directors
Dr. Norbert Windhab
Dr. Norbert Windhab
Member of the Board of Directors
Oliver R. Baumann
Oliver R. Baumann
CEO, Member of the Board of Directors
Beat Kläui
Beat Kläui
Head of Accounting & Taxation
Christian Faber
Christian Faber
Head of Legal & Compliance
Dr. Alexander Zink
Dr. Alexander Zink
Senior Scientist
Dennis Lennartz
Dennis Lennartz
Head of Investor Relations DACH
Georg Habighorst
Georg Habighorst
Senior Advisor
Marta Cao
Marta Cao
Senior Advisor
Kyra de Miroschedji
Kyra de Miroschedji
Scientific Lead of Lysatpharma GmbH
Jenny Nisser
Jenny Nisser
Research Assistant
Matthias Bohn
Matthias Bohn
Senior Advisor
Dr. Christoph Antz
Dr. Christoph Antz
CEO of Velabs Therapeutics GmbH
Dr. Martin Steiner
Dr. Martin Steiner
CEO of Synimmune GmbH
Matthias Steffen
Matthias Steffen
Managing Director of FUSE-AI GmbH
Simone Bonito
Simone Bonito
Administration

Advisory Board

Prof. Dr. habil. Michael B. Klein
Prof. Dr. habil. Michael B. Klein
Member of the Advisory Board
Prof. Dr. Johannes Schumacher
Prof. Dr. Johannes Schumacher
Expert Human Genetics
Dr. med. Ralf Oettmeier
Dr. med. Ralf Oettmeier
Chief Physician Alpstein Clinic
Dr. med. Uwe Rudolf Max Reuter, DM
Dr. med. Uwe Rudolf Max Reuter, DM
Chief Physician CLINIC in LIFE
Rainer Schnetzer
Rainer Schnetzer
Industry Expert
Dr. rer. nat. Ludger Grosse-Hovest
Dr. rer. nat. Ludger Grosse-Hovest
Expert Immunology and Antibodies
Dr. Christoph Brücher
Dr. Christoph Brücher
Industry Expert
Petra Wagner
Petra Wagner
Industry Expert, Retired member of the Austrian National Council

Sign up for our media releases

We regularly report on the business development of Xlife Sciences AG and our project companies.